In face of the everlasting battle toward COVID-19 and the rapid evolution of SARS-CoV-2,
no specific and effective drugs for treating this disease have been reported until today. …

Currently, COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has been widely spread around the world; nevertheless, so far there exist no specific …

Background SARS-CoV-2 is a novel human coronavirus, there is no specific antiviral drugs.
It has been proved that host-cell-expressed CD147 could bind spike protein of SARS-CoV-2 …

Autoimmune diseases such as ankylosing spondylitis (AS) can be driven by emerging
neoantigens that disrupt immune tolerance. Here, we developed a workflow to profile …

Growing evidence indicates that miR-146a is involved in carcinogenesis and tumor
progression in several human malignancies. However, the molecular details underlying miR-146a …

Abstracts Recent evidence suggests that CD147 serves as a novel receptor for severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-…

Major gaps in understanding the molecular mechanisms of colorectal cancer (CRC)
progression and intestinal mucosal repair have hampered therapeutic development for …

COVID‐19 patients can develop clinical and histopathological features associated with fibrosis,
but the pathogenesis of fibrosis remains poorly understood. CD147 has been identified …

CD147 is a tumor-associated glycoprotein that regulates cell metabolism. However, CD147
methylation and its subsequent role in cancer cell metabolism remain unclear. Here, we …

… Xiu-Xuan Sun contributed technical/reagents materials, analytic tools, and/or grant support;
Hong-Yong Cui, Shi-Jie Wang, Jian-Li Jiang, Ling Li and Zhi-Nan Chen prepared, wrote, …